Cameselle-Teijeiro José Manuel, Verma Sangeeta, Penn Anthony, Sethuraman Chitra, Amendoeira Isabel, Garrido-Gil Pablo, Labandeira-García José Luís, Sobrino Beatriz, Ruíz-Ponte Clara, Sobrinho-Simões Manuel
Department of Pathology, Clinical University Hospital of Santiago de Compostela, Galician Healthcare Service (SERGAS), Health Research Institute of Santiago de Compostela (IDIS), Medical Faculty, University of Santiago de Compostela, Travesía Choupana s/n, Santiago de Compostela, 15706, Spain.
Department of Histopathology, The Christie NHS Foundation Trust, Manchester, UK.
Endocr Pathol. 2025 Sep 2;36(1):31. doi: 10.1007/s12022-025-09874-z.
Thyroid lesions associated with DICER1 syndrome include multifocal hyperplastic and benign neoplastic proliferations (follicular nodular disease) with characteristic macrofollicular and/or intrafollicular centripetal papillary growth patterns, frequently associated with atrophic and involutional changes. There are also well-differentiated thyroid carcinomas showing intermediate-type nuclei, sometimes combining high-grade areas (tumor-in-tumor pattern) and poorly differentiated carcinomas. Here, for the first time, we describe an encapsulated follicular cell thyroid tumor showing a mixed follicular and morular growth pattern, which presented in an 11-year-old girl with follicular nodular disease and a constitutional (germline) DICER1 p.(Tyr1357fs18) pathogenic variant. The tumoral follicular component showed colloid and tumor cells with round nuclei, frequent chromatin clearing, and overlapping without grooves or pseudoinclusions (intermediate-type nuclei). There were scattered mitotic figures, but no tumor necrosis, infiltration, or vascular invasion. The morular structures lacked keratinization. The follicular areas were positive for TTF1/NKX2, PAX8, thyroglobulin, thyroperoxidase, keratin clones CKAE1/AE3 and 34bE12, CK19, and vimentin, whereas the morular component was positive for CKAE1/AE3, CK19, CD10, and CDX2. Aberrant (nuclear and cytoplasmic) immunolabeling pattern for β-catenin was limited to the morular structures. The Ki67 proliferation index was 21% in the follicular component and less than 1% in the morulae. In addition to the constitutional DICER1 p.(Tyr1357fs18) variant, the somatic DICER1 p.(Asp1910Tyr) oncogenic variant and the somatic CTNNB1 p.(Thr41Ala) oncogenic variant were also identified in this tumor. This "DICER1-related pediatric thyroid neoplasm with follicular and morular growth" expands the spectrum of DICER1-associated thyroid lesions. Indirectly, the absence of follicular markers only in the areas with WNT/β-catenin pathway activation (morular structures) in this neoplasm could explain the absence of follicular differentiation in cribriform morular thyroid carcinoma. The additional study of one of the accompanying thyroid nodules (follicular nodular disease) confirmed the constitutional DICER1 variant, along with DICER1 p.(Asp1709Gly) and p.(Asp1810Val) variants.
与DICER1综合征相关的甲状腺病变包括多灶性增生性和良性肿瘤性增殖(滤泡结节性疾病),具有特征性的大滤泡和/或滤泡内向心性乳头状生长模式,常伴有萎缩性和 involutional变化。也有分化良好的甲状腺癌,显示中间型核,有时合并高级别区域(肿瘤内肿瘤模式)和低分化癌。在此,我们首次描述了一种包膜性滤泡细胞甲状腺肿瘤,具有混合性滤泡和桑椹样生长模式,该肿瘤出现在一名患有滤泡结节性疾病且携带遗传性(胚系)DICER1 p.(Tyr1357fs18) 致病性变异的11岁女孩中。肿瘤性滤泡成分显示有胶体和圆形核的肿瘤细胞,染色质常清晰,细胞核重叠,无沟或假包涵体(中间型核)。有散在的有丝分裂象,但无肿瘤坏死、浸润或血管侵犯。桑椹样结构无角化。滤泡区域TTF1/NKX2、PAX8、甲状腺球蛋白、甲状腺过氧化物酶、角蛋白克隆CKAE1/AE3和34bE12、CK19和波形蛋白呈阳性,而桑椹样成分CKAE1/AE3、CK19、CD10和CDX2呈阳性。β-连环蛋白的异常(核和胞质)免疫标记模式仅限于桑椹样结构。滤泡成分的Ki67增殖指数为21%,桑椹样结构中小于1%。除了遗传性DICER1 p.(Tyr1357fs18) 变异外,该肿瘤中还鉴定出体细胞DICER1 p.(Asp1910Tyr) 致癌变异和体细胞CTNNB1 p.(Thr41Ala) 致癌变异。这种“具有滤泡和桑椹样生长的DICER1相关儿童甲状腺肿瘤”扩展了DICER1相关甲状腺病变的谱。间接地,在该肿瘤中仅在WNT/β-连环蛋白途径激活区域(桑椹样结构)缺乏滤泡标记物可以解释筛状桑椹样甲状腺癌中缺乏滤泡分化的现象。对其中一个伴发的甲状腺结节(滤泡结节性疾病)的进一步研究证实了遗传性DICER1变异,以及DICER1 p.(Asp1709Gly) 和p.(Asp1810Val) 变异。